{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:13:32Z","timestamp":1780316012682,"version":"3.54.1"},"reference-count":49,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2014,12,22]]},"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>When used appropriately, transfusion of red blood cells (RBCs) is a necessary life-saving therapy. However, RBC transfusions have been associated with negative outcomes such as infection and organ damage. Seeking explanations for the beneficial and deleterious effects of RBC transfusions is necessary to ensure the safe and optimal use of this precious resource. This study will create a framework to analyse the influence of blood donor characteristics on recipient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will conduct a multisite, longitudinal cohort study using blood donor data routinely collected by Canadian Blood Services, and recipient data from health administrative databases. Our project will include a thorough validation of primary data, the linkage of various databases into one large longitudinal database, an in-depth epidemiological analysis and a careful interpretation and dissemination of the results to assist the decision-making process of clinicians, researchers and policymakers in transfusion medicine. Our primary donor characteristic will be age of blood donors and our secondary donor characteristics will be donor\u2013recipient blood group compatibility and blood donor sex. Our primary recipient outcome will be a statistically appropriate survival analysis post-RBC transfusion up to a maximum of 8\u2005years. Our secondary recipient outcomes will include 1-year, 2-year and 5-year mortality; hospital and intensive care unit length of stay; rehospitalisation; new cancer and cancer recurrence rate; infection rate; new occurrence of myocardial infarctions and need for haemodialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Our results will help determine whether we need to tailor transfusion based on donor characteristics, and perhaps this will improve patient outcome. Our results will be customised to target the different stakeholders involved with blood transfusions and will include presentations, peer-reviewed publications and the use of the dissemination network of blood supply organisations. We obtained approval from the Research Ethics boards and privacy offices of all involved institutions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2014-007412","type":"journal-article","created":{"date-parts":[[2015,1,19]],"date-time":"2015-01-19T23:54:13Z","timestamp":1421711653000},"page":"e007412","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor\u2013recipient continuum"],"prefix":"10.1136","volume":"5","author":[{"given":"Micha\u00ebl","family":"Chass\u00e9","sequence":"first","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauralyn","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Tinmouth","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Acker","sequence":"additional","affiliation":[{"name":"Centre for Innovation, Canadian Blood Services, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane W","family":"English","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Department of Medicine (Critical Care), University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Knoll","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Forster","sequence":"additional","affiliation":[{"name":"Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Shehata","sequence":"additional","affiliation":[{"name":"Department of Medicine and Laboratory Medicine and Pathobiology, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumanan","family":"Wilson","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Institute for Clinical Evaluative Sciences, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"van Walraven","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ducharme","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Institute for Clinical Evaluative Sciences, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A","family":"Fergusson","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,1,19]]},"reference":[{"key":"2025121509172936000_5.1.e007412.1","unstructured":"Canadian Blood Services 2012 Annual Report. Ottawa. 2012."},{"key":"2025121509172936000_5.1.e007412.2","unstructured":"Rapport annuel 2012\u20132013 d'H\u00e9ma-Qu\u00e9bec. Qu\u00e9bec. 2012."},{"key":"2025121509172936000_5.1.e007412.3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.1.295"},{"key":"2025121509172936000_5.1.e007412.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1406"},{"key":"2025121509172936000_5.1.e007412.5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1537-2995.2004.04065.x","article-title":"The societal unit cost of allogenic red blood cells and red blood cell transfusion in Canada","volume":"44","author":"Amin","year":"2004","journal-title":"Transfusion"},{"key":"2025121509172936000_5.1.e007412.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902113400601"},{"key":"2025121509172936000_5.1.e007412.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1446"},{"key":"2025121509172936000_5.1.e007412.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012452"},{"key":"2025121509172936000_5.1.e007412.9","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181844677"},{"key":"2025121509172936000_5.1.e007412.10","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31822a22d9"},{"key":"2025121509172936000_5.1.e007412.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-167643"},{"key":"2025121509172936000_5.1.e007412.12","unstructured":"History of Blood Transfusion. Am Red Cross 2013. http:\/\/www.redcrossblood.org\/learn-about-blood\/history-blood-transfusion"},{"key":"2025121509172936000_5.1.e007412.13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1423-0410.2012.01584.x","article-title":"Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services","volume":"103","author":"O'Brien","year":"2012","journal-title":"Vox Sang"},{"key":"2025121509172936000_5.1.e007412.14","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMc1101692","article-title":"Anaphylaxis from passive transfer of peanut allergen in a blood product","volume":"364","author":"Jacobs","year":"2011","journal-title":"N Engl J Med"},{"key":"2025121509172936000_5.1.e007412.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-370932"},{"key":"2025121509172936000_5.1.e007412.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03330.x"},{"key":"2025121509172936000_5.1.e007412.17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000119116","article-title":"National Blood Service TRALI Reduction Policies: implementation and effect","volume":"35","author":"Chapman","year":"2008","journal-title":"Transfus Med Hemother"},{"key":"2025121509172936000_5.1.e007412.18","doi-asserted-by":"crossref","first-page":"357.e29","DOI":"10.1016\/j.amjmed.2012.08.019","article-title":"Risk factors and outcomes in transfusion-associated circulatory overload","volume":"126","author":"Murphy","year":"2013","journal-title":"Am J Med"},{"key":"2025121509172936000_5.1.e007412.19","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1111\/trf.12454","article-title":"How we view and approach transfusion-associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention","volume":"53","author":"Andrzejewski","year":"2013","journal-title":"Transfusion"},{"key":"2025121509172936000_5.1.e007412.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2012.08.009"},{"key":"2025121509172936000_5.1.e007412.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2006.05.002"},{"key":"2025121509172936000_5.1.e007412.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342601"},{"key":"2025121509172936000_5.1.e007412.23","unstructured":"Recipient Epidemiology and Donor Evaluation Study-III. Natl Heart Lung Blood Inst 2013. https:\/\/reds-iii.rti.org\/ (accessed 9 Sep 2013)."},{"key":"2025121509172936000_5.1.e007412.24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MOH.0b013e32833e73cf","article-title":"Epidemiological considerations for the use of databases in transfusion research: a Scandinavian perspective","volume":"17","author":"Edgren","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"2025121509172936000_5.1.e007412.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60779-X"},{"key":"2025121509172936000_5.1.e007412.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02583.x"},{"key":"2025121509172936000_5.1.e007412.27","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq299"},{"key":"2025121509172936000_5.1.e007412.28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1423-0410.2010.01312.x","article-title":"The PROTON study: profiles of blood product transfusion recipients in the Netherlands","volume":"99","author":"Borkent-Raven","year":"2010","journal-title":"Vox Sang"},{"key":"2025121509172936000_5.1.e007412.29","unstructured":"Mission and Goals. Inst Clin Eval Sci. http:\/\/www.ices.on.ca\/ (accessed 20 May 2013)."},{"key":"2025121509172936000_5.1.e007412.30","unstructured":"Donor Questionnaire. Can Blood Serv. http:\/\/www.blood.ca\/ (accessed 20 May 2013)."},{"key":"2025121509172936000_5.1.e007412.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2004.09.007"},{"key":"2025121509172936000_5.1.e007412.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2004.03.012"},{"key":"2025121509172936000_5.1.e007412.33","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31825f64d0"},{"key":"2025121509172936000_5.1.e007412.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.01.001"},{"key":"2025121509172936000_5.1.e007412.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.08.002"},{"key":"2025121509172936000_5.1.e007412.36","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1537-2995.2010.02655.x","article-title":"A solution to the problem of studying blood donor-related risk factors when patients have received multiple transfusions","volume":"50","author":"Middelburg","year":"2010","journal-title":"Transfusion"},{"key":"2025121509172936000_5.1.e007412.37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ahj.2009.12.045","article-title":"Duration of red cell storage before transfusion and in-hospital mortality","volume":"159","author":"Eikelboom","year":"2010","journal-title":"Am Heart J"},{"key":"2025121509172936000_5.1.e007412.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2012.01832.x"},{"key":"2025121509172936000_5.1.e007412.39","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.110543"},{"key":"2025121509172936000_5.1.e007412.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)01085-X"},{"key":"2025121509172936000_5.1.e007412.41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39465.451748.AD"},{"key":"2025121509172936000_5.1.e007412.42","unstructured":"Gwen C , Blajchman M . Clinical Guide to Transfusion. Toronto, Canada: Canadian Blood Services, 2007:1\u2013182."},{"key":"2025121509172936000_5.1.e007412.43","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.2002.35212"},{"key":"2025121509172936000_5.1.e007412.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02211.x"},{"key":"2025121509172936000_5.1.e007412.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.01026.x"},{"key":"2025121509172936000_5.1.e007412.46","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1537-2995.2009.02465.x","article-title":"Meta-analysis of clinical studies of the purported deleterious effects of \u201cold\u201d (versus \u201cfresh\u201d) red blood cells: are we at equipoise?","volume":"50","author":"Vamvakas","year":"2010","journal-title":"Transfusion"},{"key":"2025121509172936000_5.1.e007412.47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.transci.2010.05.013","article-title":"Clinical studies of the effect of blood storage on patient outcomes","volume":"43","author":"Triulzi","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"2025121509172936000_5.1.e007412.48","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.11953"},{"key":"2025121509172936000_5.1.e007412.49","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-3-2"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2014-007412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T17:17:42Z","timestamp":1765819062000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2014-007412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,19]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1136\/bmjopen-2014-007412"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2014-007412","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}